Latest Articles
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News
Published: April 15, 2026, 4:59 p.m.
Verzenio Plus Letrozole Shows Durable Responses in Advanced Endometrial Cancer - Cure Today
Verzenio Plus Letrozole Shows Durable Responses in Advanced Endometrial Cancer Cure Today
Published: April 11, 2026, 9:14 p.m.
Abemaciclib Plus Letrozole Displays Durable Activity in Advanced/Recurrent Endometrioid Endometrial Carcinoma - OncLive
Abemaciclib Plus Letrozole Displays Durable Activity in Advanced/Recurrent Endometrioid Endometrial Carcinoma OncLive
Published: April 11, 2026, 4:04 p.m.
Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer - OncLive
Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer OncLive
Published: Dec. 22, 2025, 7:02 p.m.
Low-Dose Letrozole-HMG Regimen Reverses Letrozole-Induced Endometrial Impairment and Improves Frozen Embryo Transfer Outcomes - Frontiers
Low-Dose Letrozole-HMG Regimen Reverses Letrozole-Induced Endometrial Impairment and Improves Frozen Embryo Transfer Outcomes Frontiers
Published: Nov. 25, 2025, 3:46 p.m.
Metformin Plus Letrozole and Abemaciclib Induces CRs in ER+ Recurrent Endometrial Cancer - OncLive
Metformin Plus Letrozole and Abemaciclib Induces CRs in ER+ Recurrent Endometrial Cancer OncLive
Published: Sept. 16, 2025, 2:01 p.m.
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer - OncLive
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer OncLive
Published: April 9, 2025, 2 p.m.
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer - Oncology Nurse Advisor
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer Oncology Nurse Advisor
Published: April 3, 2025, 4 a.m.
Palbociclib Plus Letrozole May Increase PFS for ER+ Endometrial Cancer - www.oncnursingnews.com/
Palbociclib Plus Letrozole May Increase PFS for ER+ Endometrial Cancer www.oncnursingnews.com/
Published: March 14, 2025, 2:07 p.m.
Link copied to clipboard!